Malley Thomas

USReporting entityDirector

Transactions

121

Issuers

Buys / Sells

13/3

Last tx

18 Mar 2026

FrançaisSign in Try free 14d

Insider

Malley Thomas

USReporting entityDirector2 companies · 24mo

Transactions

121

Issuers

Buys / Sells

13/3

Last tx

18 Mar 2026

Behaviour

4 purchases reported after at least 12 months of silence — most recent on 16 Jun 2023.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Tempest Therapeutics, Inc.	204,981	reported	13 Jun 2017	tx 19+221,208
BeOne Medicines Ltd.	26,975	reported	15 Jun 2023	tx 12+453,245
PUMA BIOTECHNOLOGY, INC.	10,000	reported	15 Dec 2014	tx 11+246,551
Kiniksa Pharmaceuticals International, plc	0	reported	14 Aug 2025	tx 36+440,458−440,051
Kura Oncology, Inc.	0	reported	18 Mar 2026	tx 15+345,500
TRIMERIS INC	0	reported	22 Jun 2015	tx 21+50,700−120,027
SRKP 4 INC	0	reported	03 Jul 2009	tx 8+59,918−59,918

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
18 Mar 2026	EXERCISE	Kura Oncology, Inc.	10,000	3.12 USD
18 Mar 2026	EXERCISE	Kura Oncology, Inc.	10,000	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	10.36 USD
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	30,000	9.88 USD
13 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	50,129	33.32 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	18,760	15.47 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	33,237	14.33 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	26,236	15.19 USD
14 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	78,233	33.09 USD
12 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	49,407	32.40 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	21,959	1.86 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	27,448	3.80 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	21,959	0.00 USD	deriv
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	27,448	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	30,000	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	18,760	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	26,236	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	33,237	0.00 USD	deriv
05 Jun 2025	GRANT_AWARD	Kura Oncology, Inc.	28,500	0.00 USD	deriv
05 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	3,173	—
05 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	3,173	0.00 USD	deriv
03 Jun 2025	GRANT_AWARD	Kiniksa Pharmaceuticals International, plc	2,799	0.00 USD	deriv
03 Jun 2025	GRANT_AWARD	Kiniksa Pharmaceuticals International, plc	16,798	0.00 USD	deriv
05 Jun 2024	GRANT_AWARD	Kura Oncology, Inc.	26,000	0.00 USD	deriv

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Tempest Therapeutics, Inc.	204,981	reported	13 Jun 2017	tx 19+221,208
BeOne Medicines Ltd.	26,975	reported	15 Jun 2023	tx 12+453,245
PUMA BIOTECHNOLOGY, INC.	10,000	reported	15 Dec 2014	tx 11+246,551
Kiniksa Pharmaceuticals International, plc	0	reported	14 Aug 2025	tx 36+440,458−440,051
Kura Oncology, Inc.	0	reported	18 Mar 2026	tx 15+345,500
TRIMERIS INC	0	reported	22 Jun 2015	tx 21+50,700−120,027
SRKP 4 INC	0	reported	03 Jul 2009	tx 8+59,918−59,918

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
18 Mar 2026	EXERCISE	Kura Oncology, Inc.	10,000	3.12 USD
18 Mar 2026	EXERCISE	Kura Oncology, Inc.	10,000	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	10.36 USD
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	30,000	9.88 USD
13 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	50,129	33.32 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	18,760	15.47 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	33,237	14.33 USD
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	26,236	15.19 USD
14 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	78,233	33.09 USD
12 Aug 2025	SALE	Kiniksa Pharmaceuticals International, plc	49,407	32.40 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	21,959	1.86 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	27,448	3.80 USD
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	21,959	0.00 USD	deriv
12 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	27,448	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	20,129	0.00 USD	deriv
13 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	30,000	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	18,760	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	26,236	0.00 USD	deriv
14 Aug 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	33,237	0.00 USD	deriv
05 Jun 2025	GRANT_AWARD	Kura Oncology, Inc.	28,500	0.00 USD	deriv
05 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	3,173	—
05 Jun 2025	EXERCISE	Kiniksa Pharmaceuticals International, plc	3,173	0.00 USD	deriv
03 Jun 2025	GRANT_AWARD	Kiniksa Pharmaceuticals International, plc	2,799	0.00 USD	deriv
03 Jun 2025	GRANT_AWARD	Kiniksa Pharmaceuticals International, plc	16,798	0.00 USD	deriv
05 Jun 2024	GRANT_AWARD	Kura Oncology, Inc.	26,000	0.00 USD	deriv